Google TrendLAMINE YAMAL (2000+) — "You want to play for Morocco?": Getafe defender provokes Yamal with shocking words
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Dr. Spratt on an AI model" (27 stories)

Top Headline Story

Multi-modal AI for comprehensive breast cancer prognostication
Lead StoryNaturetech
May 20

Multi-modal AI for comprehensive breast cancer prognostication

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9rUGdhdTFLNHFOYllZZ0RvdzJEcENKMF9sdWE4YW1jcUdEcEZkQ2hUSjIzcVBEMHNrZ3pVenh2alNtZ1FEYVJ6ZjA1d2F5a0ZUSXN2SmF3SEhLT29SUjVr?oc=5" target="_blank">Multi-modal AI for comprehensive breast cancer prognostication</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
2000+21m ago

lamine yamal

"You want to play for Morocco?": Getafe defender provokes Yamal with shocking words

500+31m ago

abdulrahman alfozan

OpenAI engineer arrested in bugging of executive conference room

500+31m ago

pope francis

The Myth of St. Francis

500+31m ago

olise

Bayern’s Michael Olise sent off for 2 yellow cards within seconds in Champions League

Search Results for "Dr. Spratt on an AI model"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

26 stories displayed
Dr. Spratt on an AI model predictive of hormone therapy benefit in men with prostate cancer
Urology Timestech

Dr. Spratt on an AI model predictive of hormone therapy benefit in men with prostate cancer

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTmtKNkdJSHA0cl9QWlZhQ2RTVGdpam05aURnZWV0a2pOZFFTSFVtWGkwVFNvcFVsSzIwcEYtSzZ5UWhDN3EwMG5GcTdncVkxQlNHNjNxc2c4X1FuOGRZTG5hUk1MQzhYYktkWi1ULVhVYjNwMXp5VEQwcmF0VDBHZEMwbHZOSG9peWlpZG5tY29UUjVpN0NFR3VHYXlXN1ZhV2kwQ3VsZ3JadUxDR24yWFBOMFJkOHUtZ28yWlFySmJ6UQ?oc=5" target="_blank">Dr. Spratt on an AI model predictive of hormone therapy benefit in men with prostate cancer</a>  <font color="#6f6f6f">Urology Times</font>

Combining Genomic Classifier and Digital Pathology Artificial Intelligence in Prostate Cancer Risk Stratification - Daniel Spratt
UroTodaygeneral

Combining Genomic Classifier and Digital Pathology Artificial Intelligence in Prostate Cancer Risk Stratification - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMirwJBVV95cUxNOHdia0xFT1VZeHhBamxYbDBPallFdDVnMG1DZmhJUFJGN0E2LVkwRHU3cGU1eGItakFwVTJQT0lkUVU5Vzc0czFZNFJqdi1GT3lzUkdBbEI4QUJGRW5KV0JSZGJMNGI2M3dueURONW4wbUpUMEN4MUZVeUJIaVNYdlkxSFN1dWZsWXNSUG9zdU1BZHVsOHBGVmRRLUlHMFpRWXpNV0pZM1A2UjFENEFqMzcxR2VTS1p5M2w1b3ZzbUg3bmpkZ3hkakh6U2lfT004Um5PT3c1YkpNQkdQRS1SRnE4d1BnbldQaFRxV0FHQ1gzOWxyNzFuMjJUakdrY1VKeWE2bjJXR01NTmlOZTZmNHhmMWlyZ2hoVFNpbXdnVnNyZXB5czdVeGJ0djJNRlk?oc=5" target="_blank">Combining Genomic Classifier and Digital Pathology Artificial Intelligence in Prostate Cancer Risk Stratification - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

AI-Based Predictive Model Could Spare Use of Prostate Cancer ADT
Renal and Urology Newstech

AI-Based Predictive Model Could Spare Use of Prostate Cancer ADT

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPUlJCM3M4cGI4bkFEQ2lxNld2Zi1aQnZtYUQ0WWZDbkU2R0R6VVgxeVkwcjNKaEZfUDVMb2lBWGFCeW1DNV9MakVnOGJiMHJ2Yjg1WnlFQ2RWUzdZcElreWU3ZEt1ZDlOVmowZGRmSEZZTnZudWRmS2dRUENKMDd1ZWZncWlrYWJMeWNBNUxLOGFnMU9sdTdxeWFOZ1BZZ0FRNkxMczBwMGd4OFJzQnlF?oc=5" target="_blank">AI-Based Predictive Model Could Spare Use of Prostate Cancer ADT</a>  <font color="#6f6f6f">Renal and Urology News</font>

AI and the Visual Arts: Generative AI and the Art of Disruptive Innovation
Columbia University Club of Washington, D.C.tech

AI and the Visual Arts: Generative AI and the Art of Disruptive Innovation

<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE9Gbmp2VFlEZXFKWFFlNS1QcEwwaHdmNXQtTG0yaGREeVdjZkUxT3M0NjNXaVZyTmNubEZzbXdKaGF6UzhSelBtSlNxdlR2amdlXzhYbA?oc=5" target="_blank">AI and the Visual Arts: Generative AI and the Art of Disruptive Innovation</a>  <font color="#6f6f6f">Columbia University Club of Washington, D.C.</font>

Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
NEJM Evidencegeneral

Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9IejgzVEdlelRwMlRqNzMzU2NHcjliQ3JpT0cxa3BTTWQ1N2Q1aERPRjRZeDN2Nl95Q0l0SG5Mb0p2Sk1rRFdIc0pIY0p1R1B5Z25PdDhBenRiSmNDYjRsdHFJc1JKMHc?oc=5" target="_blank">Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer</a>  <font color="#6f6f6f">NEJM Evidence</font>

AI Model IDs Patients to Best Benefit from ADT for Prostate Cancer Treatment
Clinical Lab Productstech

AI Model IDs Patients to Best Benefit from ADT for Prostate Cancer Treatment

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxON1ltSW9GdmZkYlYwalBTUWRpNnB5MV9FSnVhRjFMeFNydVNZYlQ3NUFUcE5yLUdVcGFraXU1YW56LWFvMnFielFoRUZiVHZaQWpOLW5LbHdEMjFpM2thUkpwOTZ3VXhvOG1CLXRjY1ltc0g2dzVyVGs4V3YtZjdWNXhBb1NlV2RMd1JFTElxMEVWMnR1SHBBUHI4VTZqanpaaFFSbV9Ga1pQTTljLThmeFVsYUx5MXdWaW11bHU1R2FocTQ?oc=5" target="_blank">AI Model IDs Patients to Best Benefit from ADT for Prostate Cancer Treatment</a>  <font color="#6f6f6f">Clinical Lab Products</font>

AI May Predict Benefit with Hormone Therapy Plus Radiotherapy in Prostate Cancer
Cure Todaytech

AI May Predict Benefit with Hormone Therapy Plus Radiotherapy in Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOekhyZElyZjNjQ3BZMEZrcHpwbFZhR08zcFBBbjFLLXJLdmw3T0NvazVoOEpyc0YwRTRQLXdmMjVWVVM5ek0taDF0czVrd3NQMEV5QzBheEp3NGFIb2ZIYXQ4TTNJc0NneC1XNDE2ejVxSVYwU3pOWlFxSGp2dExodmJpMnBmNzNBVHVrN25VTkdXYWFyLVh1WU1meDFQY01aSDhXYVdveGhfM1liRlFMdQ?oc=5" target="_blank">AI May Predict Benefit with Hormone Therapy Plus Radiotherapy in Prostate Cancer</a>  <font color="#6f6f6f">Cure Today</font>

Dr. Emily Spratt to teach course on Visual Culture, Diplomacy, and Artificial Intelligence
The Institute of World Politicsgeneral

Dr. Emily Spratt to teach course on Visual Culture, Diplomacy, and Artificial Intelligence

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxPdFJBTmlPTVRvRGdhS3NGOWpjWERrWTlKS1NWUHJ4WFRzZklmNjZIQU03RTlneHVTVDF2Q05ERnhtY2gwOUJzTEF4TkZsdVNnZWo5X3VMYnJYd2JMOXl3bmJkQUx3QVhrZHU1WXpzZHhQSUVKYUZ4ZExIUW1qSkI5eWtHVWhnVWdUS3ktNkc5bGkyLTBGTmtZQTVvUkk2dWNMR21lQWtDQUgwX0dtaDBFVHJtcEZmcHkyQTZ4MVllVTM0UTNKODdSeG5CdkJTeDdKUTJjYmZ1YzNDQ0sz?oc=5" target="_blank">Dr. Emily Spratt to teach course on Visual Culture, Diplomacy, and Artificial Intelligence</a>  <font color="#6f6f6f">The Institute of World Politics</font>

Dr Spratt on the Use of Radiation in Low– and High-Risk Prostate Cancer
OncLivegeneral

Dr Spratt on the Use of Radiation in Low– and High-Risk Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPaXlnSWd1OWpzaXZkekdNYTVDYUh3N09sRURPVmo1dEJTSHNfVFUtM0lBZ21NNzl6elM3WWU2TzhmOTdvZHdaeXR6cmg0ajNMWDVIekVwbTMwd0tPTVZscmVWSU15czVTdGZhLTVFbTFvbUdZYnNpMTJhNGJWT3RHSEZ6cDJXUUw0aUVRY2tmeTY0bFctYXBXUHNka1BvMkV0?oc=5" target="_blank">Dr Spratt on the Use of Radiation in Low– and High-Risk Prostate Cancer</a>  <font color="#6f6f6f">OncLive</font>

Dr. Spratt on the potential use of an AI biomarker in treatment decision making for prostate cancer
Urology Timestech

Dr. Spratt on the potential use of an AI biomarker in treatment decision making for prostate cancer

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNRkZNeE44VmhLX1UyTkZFN0tFVXQxRUl1QjVIck1FVzJNUTdXQ1BlSkZ6VmdrSHNQN3l3WkhHeG1QTU1oNmFDVXJKSXIwbDZjaXBka2R3V0RKcGRGRUhRNWpBWnhXLTRQeExwZjE1V2w2MkoxcHRXMUs0d2gyRzN5Q2dRTUxKSk9xQklnSGQta3dqZzl4LXI5LU51c3FzZmVrcEt1bTZ1QVhNdUZ5T3VIVmdxTldVb1NHMGl2OTF4NDAzS1JsZFhyc2FtZ08?oc=5" target="_blank">Dr. Spratt on the potential use of an AI biomarker in treatment decision making for prostate cancer</a>  <font color="#6f6f6f">Urology Times</font>

These are the panelists for the Observer’s AI & Theology conference
The Orthodox Observertech

These are the panelists for the Observer’s AI & Theology conference

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOMWVTYkd1VkpTNjJlVUNVMWNVbXFlVmdHZzBWRjBzWFFMVnAwbVFET3h2NmF1SHlQSTJmSTNlU19sVWk3ZU5sNmJNTDQ1d3g0NzFBbTV4WnNtcXRRUF9ncjNmX2VwS3ZtWmJFVEJuNTg5aHhFOWZ4MUIwc2JUTC1fVTRHY3JFLVdvMDlXWmZaem5HemdRMTB6RnBR?oc=5" target="_blank">These are the panelists for the Observer’s AI & Theology conference</a>  <font color="#6f6f6f">The Orthodox Observer</font>

ASCO GU 2025: Risk Stratification Using the Decipher® 22-Gene Genomic Classifier and Digital Pathology Artificial Intelligence in Nearly 10,000 Localized Prostate Cancer Patients
UroTodaygeneral

ASCO GU 2025: Risk Stratification Using the Decipher® 22-Gene Genomic Classifier and Digital Pathology Artificial Intelligence in Nearly 10,000 Localized Prostate Cancer Patients

<a href="https://news.google.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?oc=5" target="_blank">ASCO GU 2025: Risk Stratification Using the Decipher® 22-Gene Genomic Classifier and Digital Pathology Artificial Intelligence in Nearly 10,000 Localized Prostate Cancer Patients</a>  <font color="#6f6f6f">UroToday</font>

Artificial Intelligence Enhances Assessment of Prostate Cancer Extent
Renal and Urology Newsgeneral

Artificial Intelligence Enhances Assessment of Prostate Cancer Extent

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTFBZc0tGVHRBemRHaC0yMUZzdEQyYUZIY1NMQU81dkJnby1iU0ZOYjVXcC1rYXNVNHV0dlFRSVFHcldUQ0F1UUMyUWktbU80ZjVmNkQzdjQzQS1TMjROdk82NEZ0QjNpQmp3SXZxdmVaMHlHUQ?oc=5" target="_blank">Artificial Intelligence Enhances Assessment of Prostate Cancer Extent</a>  <font color="#6f6f6f">Renal and Urology News</font>

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer
Naturegeneral

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE90MmR4OWd4UkJiYlpVOFFEY2Z2WjlyeUFjbGU3NEpzbGE4eFM5MU45S1lxZjNldXNBTGtQLUc2YWlsNlRuWTg3MnRlR3JWeEg5Zkt4TVh3UFZibjEwTUY0?oc=5" target="_blank">Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer</a>  <font color="#6f6f6f">Nature</font>

Dr Spratt on Uncertainties Regarding Treatment Intensification in High-Risk Prostate Cancer
OncLivetech

Dr Spratt on Uncertainties Regarding Treatment Intensification in High-Risk Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPZTROUUwzREZDZk5CRkE2anlmT3VRT1RvWG43S0FmbXdEMkRsMmpwdDdkaElpckoyTFp4UlJOeVpGQW5NdElxckxNNmVCaGhJRVU4QXdIbkx4S29YRWx6azVIUjNjY3Jua05JN2pzWS00ZzJHb3NSTVVmeHYzTnZnODhLM2Q0aU5zOU1KNzFxenNFeUhRbWFQVGRVZEQtVkIyYzFhUDBwd1M2dlh1YmZGRllhYURSQkExRmR4VQ?oc=5" target="_blank">Dr Spratt on Uncertainties Regarding Treatment Intensification in High-Risk Prostate Cancer</a>  <font color="#6f6f6f">OncLive</font>

APCCC 2024: Genomic Classifiers and Artificial Intelligence as Predictors for Treatment Benefit
UroTodaygeneral

APCCC 2024: Genomic Classifiers and Artificial Intelligence as Predictors for Treatment Benefit

<a href="https://news.google.com/rss/articles/CBMi9wFBVV95cUxQbGhJN083TDRDbnlxWWdfSHZtZDlRTEJJUnQ1UDFzVHppOFdEbkNFaG52R3VRVWxjcTV3b1RmbU9wTEd5QTNVSGpBcHFhaWRKcVpfZG9IbVVrN1htc05JRzFkWTBnM0lfcnZ5QW9GQTI3dDJnUUFQUkVYcFRlRlhtUlA2U3kwSjkxRkJnVmtkZnRReHNwYjF4TG5OM1QtRlBoMFVGdndDaHgxQTVlVUtZWkNHR2plbWFacWxJWmNadDBPWUh0ZFlwM1BYRmRLTlJlTnRuT0dZNTVLcm8xQWQ0WnFEVEdsbzRTYVlmSXczVnBRdmtuWWtr?oc=5" target="_blank">APCCC 2024: Genomic Classifiers and Artificial Intelligence as Predictors for Treatment Benefit</a>  <font color="#6f6f6f">UroToday</font>

MMAI Model Risk Stratification for NCCN Guidelines for Low, Intermediate, and High-Risk Prostate Cancer - Neal Shore, Daniel Spratt, & Alicia Morgans
UroTodaytech

MMAI Model Risk Stratification for NCCN Guidelines for Low, Intermediate, and High-Risk Prostate Cancer - Neal Shore, Daniel Spratt, & Alicia Morgans

<a href="https://news.google.com/rss/articles/CBMi1wJBVV95cUxQSXdkcy1VbW9oMU5zaURIalh3M01HRHdLd1NvSG9USkJNazgzS05CX0U5V0szVEdFVzVjSEVmdUlfNVZQOXNWMTJsS2s4bUpKNXBRRWFMSmJXVlZ1aGRwQkZuRlBGeThYQ1VELW1ITGVpbG0tejZEZHJ4SVBGT3R6TFVYSjloTkF6Q2lCMk9jZUxndW9HY3haMWdHcnFteTloY0dzSHdhQlZoX2h4NC1VWkg2RkN5Y2UtZkFIZWd6Y0JwNWNacThXN0l1XzlLbW5ILVlUck82TmpwR1pXWlZsRWpzMXl5bHh4akZtcEdWRUkxaW9HcDhiX1RCenhyaHQtOXpIQVJDc3VfX3otS0ZIVDROMlJpYnNVLS1qTHB5ajdKMXBxWmJoUWNDZnlrbkNoU2hhN2FqYTQyWnZUYnN5YnpTUW5BVjRxdV9DY3IxYks5cXkzMWxB?oc=5" target="_blank">MMAI Model Risk Stratification for NCCN Guidelines for Low, Intermediate, and High-Risk Prostate Cancer - Neal Shore, Daniel Spratt, & Alicia Morgans</a>  <font color="#6f6f6f">UroToday</font>

Biomarker-Driven Apalutamide Therapy for Patients With Recurrent Prostate Cancer
The ASCO Postgeneral

Biomarker-Driven Apalutamide Therapy for Patients With Recurrent Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPVEZyMWl3elNqZl9kSFp4UDZyNjMxT2RkWmZQRl9OOWh2eFlLQ0hBRVNkSnB0MVlnckxtQ1RJb1FiRW1PdjV3S1lHNWlsUjVmNXpJa3UwU0U1UjhGcHVKYjV2eVllRzExT3RqTGJMX3oyZmVYWWhsZXFzbnpUV0piMVdrU1BqVV9WdGVzWVNMN0cwOHU3T1pRRHloQUpXSUJBT3I0Q3FZVFVoX2ZFVnVJNmhXVlo2alV2S1NBSTE3dEJGV3c?oc=5" target="_blank">Biomarker-Driven Apalutamide Therapy for Patients With Recurrent Prostate Cancer</a>  <font color="#6f6f6f">The ASCO Post</font>

Dr Spratt on Sequencing Radiation Therapy and Hormone Therapy in Prostate Cancer
OncLivegeneral

Dr Spratt on Sequencing Radiation Therapy and Hormone Therapy in Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNZDZNMFk5cFZld2hacWdIWlRnNXFMX1doVmFUcmdTbmg0bkRsU1ZOdFRpOEdrQ29Kc196V24tVU5KcmhzeGdjUUhvbTh3LU9YVlB3U1JOSGtaOWVIVElvYXBoLTZyZWFOaXFfZTJQRHpsbHlTMm0yUlp0RDZLME1xQVBWM1Nod3VqVFEwaXNsZXlYTjVLUzZMSkpGUGpOSWNYeksyQ2JjZWNmT0M0NWc?oc=5" target="_blank">Dr Spratt on Sequencing Radiation Therapy and Hormone Therapy in Prostate Cancer</a>  <font color="#6f6f6f">OncLive</font>

A new study published in NEJM Evidence with University Hospitals Seidman Cancer Center researchers and ArteraAI validates the first-ever predictive AI biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer
EurekAlert! Science News Releasestech

A new study published in NEJM Evidence with University Hospitals Seidman Cancer Center researchers and ArteraAI validates the first-ever predictive AI biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer

<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE9GN2xPUHlrSTJZRXk1R0k3VVlkdWtDS3NBRlBqQWVDSUJ0RUUwRjhWTzg5TVdaU191XzdFWF9SbXlNQklSWHhiWDZUQ2Uwa0NRNTE3WHhOaUo0Wjg?oc=5" target="_blank">A new study published in NEJM Evidence with University Hospitals Seidman Cancer Center researchers and ArteraAI validates the first-ever predictive AI biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer</a>  <font color="#6f6f6f">EurekAlert! Science News Releases</font>

Role of Radiation Continues to Grow in the Treatment of Prostate Cancer
OncLivegeneral

Role of Radiation Continues to Grow in the Treatment of Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPc2tBaDVEU2lWV1FXUW9SRTQ0azBiczFsYmhkSVBzR0tlcG8tQVp1TnVCdXB5ZGNaaUlXN0lhVHN3M0JSLVd4dGczVTVTMk96YUpzby1nUnlncVpSSGhBeGxKeC1tU3VjWEkxOFlMZjVUTG9ERWlSUFBUMlljb3hzV3JhTkw4OG5KNy1PdlRvbWlhSlpoNFJ3TXlVeFRpTkZoMmc?oc=5" target="_blank">Role of Radiation Continues to Grow in the Treatment of Prostate Cancer</a>  <font color="#6f6f6f">OncLive</font>

Personalizing Salvage Radiation and Hormone Therapy for Biochemical Recurrence - Daniel Spratt
UroTodaygeneral

Personalizing Salvage Radiation and Hormone Therapy for Biochemical Recurrence - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxPM0FmQTU2VTRFeVlLd3AxMDNDcXlxTkg0MjhoamEzMFJjXzdEMldxaHZuQlpKQ0VpemFuYUlzOGlMTE05Wm1tUDgwOXlUUXdsbXRfWHV2cDRlOFdBNnA0UDcxOFlMaXVmcDFjdWhJUk8yYjk5eFBNT3diWVRINXk5MU8xZ0JXOEpoTW9fYzBsX0NUS3pZVVoxal9yZ3M0NGQzcXhWSjlPYll4UV92cmJVYXRoZzhqUW1rYzJkTEZPbjRJMWhDbVE2SW1OaUhGQURjUVhtcHNILWZKaHRFai1rcjNlMXF4a0k5ME5RUVA4V1UwVzBpc2lCVTQ2OHk3VWlyaWZR?oc=5" target="_blank">Personalizing Salvage Radiation and Hormone Therapy for Biochemical Recurrence - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

PAM50 Subtyping Identifies Patients With Prostate Cancer Most Likely to Benefit From Apalutamide
The ASCO Postgeneral

PAM50 Subtyping Identifies Patients With Prostate Cancer Most Likely to Benefit From Apalutamide

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPX0llZWpEcW9UaXBTeTVMVHVBNF9aWWRTM1JGTmlIUVMxSjZnVjhOWDBTSmpUV2g0WjJQaWlFRm1mTU9PQ0huXy1IZVZxZlF3S1RmOUtFTTIwTnpIOEp4WjFGc09qR09KRXRrbHMyVGlXTzRBc2FPRXNrcWVfQktDS3B5eGxjRkdOdXMwNi1UdEtYZmNzM1F4ODJpc1NuRkFXQUVJY3d6U25BRVptWGpEUm5yaWJNLUxoVXlvV0h5bWt0OERGMHVvTkpncXdJN0hVVnpXTQ?oc=5" target="_blank">PAM50 Subtyping Identifies Patients With Prostate Cancer Most Likely to Benefit From Apalutamide</a>  <font color="#6f6f6f">The ASCO Post</font>

New AI tool at University Hospitals helps men with prostate cancer skip unnecessary treatment, avoid side eff
Cleveland.comtech

New AI tool at University Hospitals helps men with prostate cancer skip unnecessary treatment, avoid side eff

<a href="https://news.google.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?oc=5" target="_blank">New AI tool at University Hospitals helps men with prostate cancer skip unnecessary treatment, avoid side eff</a>  <font color="#6f6f6f">Cleveland.com</font>

Dr. Spratt on Combination of Immunotherapy and Radiation in Prostate Cancer
OncLiveworld

Dr. Spratt on Combination of Immunotherapy and Radiation in Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQeDhBM0k4S3FmcEQtNXVUWC1nRVlUaWlrQURTRnNYVzU3Y2ozc1J4M2piQTh3U1E4YW1kbWlQWXlnMklOZnd6SWxuWElTMkJOQ1BnSjBzYUdLMkxqU0liY3ViR2FzN19vNnY0aHZDUHlJWGRGczJhdU9USGNSTW9FbE1ReUdscEdtOWE2SEpseHJLRFpLSXE4MHdEZHo5X3FHTTZKSHNB?oc=5" target="_blank">Dr. Spratt on Combination of Immunotherapy and Radiation in Prostate Cancer</a>  <font color="#6f6f6f">OncLive</font>

Danbury Hospital Simulation Center Earns National Accreditation
Patchgeneral

Danbury Hospital Simulation Center Earns National Accreditation

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNQ3hQeG02VmRiUjkwUDgtc1ZCbVVwb21yZHRRU0gtLWlZakU0VEd6d0hja0dxYW42S2pJa0xMRkRNUFQ3RTVwVzNMZk0zb1RkTUkwZ3l2enhUV2NpUGhEWV96Y1p4UldJOHZ0ZVFYaWhGNnpDWERYLWhMNDlzbzNGYlpDMnlQRUM3cmZFaUxBRWlQZmh3VDQxMXlnZi1IQkJ4ZC1r?oc=5" target="_blank">Danbury Hospital Simulation Center Earns National Accreditation</a>  <font color="#6f6f6f">Patch</font>

"Dr. Spratt on an AI model" — Live Google News Trends & Headlines